Literature DB >> 23555389

Long-term Results of Reconstructive Surgery for the Unilateral Aortoiliac Occlusive Disease and Future Risks of Contralateral Iliac Events.

Toshihiro Onohara1, Takeshi Takano, Maki Takai, Haidi Hu, Takahiro Ohmine, Ryota Fukunaga, Tadashi Furuyama, Yoshihiko Maehara.   

Abstract

OBJECTIVE: Our experience with unilateral iliac reconstructive surgery was retrospectively reviewed, and the long-term patency and the morphological information was disclosed. In addition, the prognosis of contralateral iliac artery was examined, because future contralateral iliac events seem to be important for durability of unilateral iliac revascularizations.
MATERIALS AND METHODS: 148 patients (mean age, 66.9 years; 88% male) who had undergone unilateral aortoiliac reconstruction without contralateral iliac lesions were evaluated. The unilateral aortoiliac reconstructive procedures included 112 (76%) aorto or iliofemoral bypasses, 27 (18%) femorofemoral bypasses, and 9 (6%) axillofemoral bypasses. The indications for arterial reconstruction were disabling claudication and limb salvage in 125 (84%) and 23 (16%) patients, respectively. Preoperative arteriograms were reviewed to determine the Inter-Society Consensus (TASC II) classification categorizing iliac artery lesions. Contralateral iliac events were defined as any arterial reconstructive procedure, intervention, amputation for progression of contralateral iliac disease, or repair of abdominal aortic aneurysm (AAA). The Kaplan-Meier survival analysis was used to predict long-term results in patients grouped based on various factors which were compared using univariate and multivariate analyses.
RESULTS: In the 148 patients, unilateral iliac reconstructive procedures were undertaken in 83 (56%) patients with TASC II type D lesions, 34 (23%) patients with TASC II type C lesions, and 31 (21%) patients with TASC II type B lesions. Overall primary and secondary patency rates were 93.8% and 96.5% at 3 years and 90.0% and 93.9% at 5 years. A multivariate analysis disclosed critical limb ischemia influencing primary patency rates, and type of aortoiliac reconstruction or gender influencing secondary patency rates. TASC II classification did not affect primary or secondary patency rates. During the follow-up period, 15 contralateral iliac events occurred, including 11 aortoiliac reconstructive or interventional procedures, 3 repairs of AAA, and one case of bilateral thigh amputation due to acute aortic occlusion. The overall probability of contralateral iliac events was 2.2% at 3 years and 5.9% at 5 years.
CONCLUSION: The long-term patency following unilateral iliac reconstructive surgery was satisfactory, and not affected by morphology of the iliac artery. Also, the future risk of contralateral iliac events appeared to be low.

Entities:  

Keywords:  contralateral limb; prognosis; unilateral aortoiliac reconstruction

Year:  2010        PMID: 23555389      PMCID: PMC3595821          DOI: 10.3400/avd.AVDoa09033

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  26 in total

1.  Local blood serotonin and soluble P-selectin levels during percutaneous transluminal balloon angioplasty and primary stenting of the iliac artery.

Authors:  Toshihiro Onohara; Kimihiro Komori; Hiroyuki Inoguchi; Shinji Yamamura
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

3.  Primary iliac stenting versus transluminal angioplasty with selective stenting.

Authors:  Ali F AbuRahma; J David Hayes; Sarah K Flaherty; William Peery
Journal:  J Vasc Surg       Date:  2007-10-01       Impact factor: 4.268

4.  Patterns of treatment for peripheral arterial disease in the United States: 1996-2005.

Authors:  Vincent L Rowe; William Lee; Fred A Weaver; David Etzioni
Journal:  J Vasc Surg       Date:  2009-04       Impact factor: 4.268

5.  Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions.

Authors:  Irfan I Galaria; Mark G Davies
Journal:  Ann Vasc Surg       Date:  2005-05       Impact factor: 1.466

6.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

7.  Long-term outcomes and predictors of iliac angioplasty with selective stenting.

Authors:  Toshifumi Kudo; Fiona A Chandra; Samuel S Ahn
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

8.  Unilateral iliac artery occlusive disease: a randomized multicenter trial examining direct revascularization versus crossover bypass. Association Universitaire de Recherche en Chirurgie.

Authors:  J B Ricco
Journal:  Ann Vasc Surg       Date:  1992-05       Impact factor: 1.466

9.  Unilateral vascular reconstruction for iliac obstructive disease.

Authors:  J A van der Vliet; D M Scharn; J W de Waard; R M Roumen; S F van Roye; F G Buskens
Journal:  J Vasc Surg       Date:  1994-04       Impact factor: 4.268

10.  Iliofemoral versus femorofemoral bypass: the case for an individualized approach.

Authors:  M E Harrington; E B Harrington; M Haimov; H Schanzer; J H Jacobson
Journal:  J Vasc Surg       Date:  1992-12       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.